Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 71 to 80 of 166 resources

  • Hepatitis C Virus Infection and Alcohol: Challenges and Opportunities
    This report, prepared by Professor David Goldberg and supported by Bristol Myers-Squibb, looks at the linkages between excessive alcohol consumption and hepatitis C, and explores how excessive alcohol consumption can act as a barrier to people with hepatitis C being considered for, receiving and the benefit of treatment for hepatitis C.

    The report contains a number of recommendations, including that for hepatitis C-infected people whose consumption of alcohol exceeds mild levels, the management of such consumption should be taken as seriously as the management of their hepatitis C.
    UK Jun 2015 Other, Reports & Research, Strategy & Planning PDF
  • Hepatitis C in the North West - PHE 2014 report
    The Public Health England North West annual hepatitis C report (published 22 June 2015) reveals that in 2014 at least 40,000 adults in the region are estimated to be infected with hepatitis C, with the highest burden of disease in Greater Manchester. Estimates indicate that the greatest numbers of people in the North West living with hepatitis C live within Lancashire, Manchester and Liverpool.
    North West Reports & Research, Strategy & Planning PDF
  • Summary Report: Hepatitis C Good Practice Roadshow, Liverpool
    This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England on 6th March 2015, in Liverpool. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes an overview of talks on the day; a write-up of the workshop on the 'Anchor Model of Care' for hepatitis C and group work notes; and suggested next steps for Cheshire and Merseyside with the aim of eliminating hepatitis C as a serious public health concern in the area.
    North West May 2015 Case study, Reports & Research, Strategy & Planning PDF
  • Measuring the impact of the recommendations of the London Joint Working Group on Substance Use and Hepatitis C - learning from the pilots
    In 2011 the London Joint Working Group published 'Tackling the Problem of Hepatitis C, Substance Misuse and Health Inequalities: a Consensus for London'. The document set out a number of recommendations to improve the integration of services in London for people with hepatitis C and a history of using drugs. In 2013 the group aimed to assess the impact of its recommendations by setting up a pilot project in four London boroughs.
    UK, England, Greater London May 2015 Case study, Other, Reports & Research, Strategy & Planning PDF
  • Improving Outcomes for People with Blood Borne Viruses in Dundee
    Dundee CHP supported a pilot piece of work in February 2013 by inviting all GP Practices to submit an audit of their BBV patient population. This resulted in 20 out of 26 Practices in Dundee satisfactorily completing the audit, which gave both the CHP and MCN an overview of the information, held by GPs.

    UK, Scotland May 2015 Case study, Reports & Research PDF
  • Together for Health -Liver Disease Delivery Plan
    The Liver Disease Delivery Plan, launched by the Welsh Government and NHS Wales in May 2015, seeks to prevent liver disease and improve related services, and includes a focus on addressing viral hepatitis in Wales.

    The Plan aims to halt the ride in liver disease and deaths; provide more support to patients; improve the quality of services' improve specialist knowledge in liver disease throughout the health service, and encourage patients to take responsibility for their health and care.
    UK, Wales May 2015 Other, Strategy & Planning PDF
  • Hepatitis C: Inequalities in Access to Medicines
    This study by IMS Health seeks to understand the barriers to more effective treatment for hepatitis C in England. Among its findings were that inequalities in access to hepatitis C treatment are becoming more pronounced, and that treatment rates are actually falling among the most deprived patient groups.
    UK, England Mar 2015 Reports & Research PDF
  • HCV Action & PHE hepatitis C roadshow in Liverpool: Presentations
    On 6th March 2015, HCV Action and Public Health England staged a hepatitis C good practice roadshow in Liverpool. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in the Merseyside area.
    UK, England, North West Mar 2015 Case study, Other, Reports & Research, Strategy & Planning PDF
  • HCV Action good practice film: Community-based treatment in Lambeth
    In this good practice film, HCV Action interview Katherine Oakes, Senior Nurse for Viral Hepatitis at Kings College Hospital, and Dee Cunniffe, Policy Lead and Project Manager at the London Joint Working Group on Substance Use and Hepatitis C. They talk about the outreach service established in Lambeth to provide specialist care to hepatitis C-infected substance users in the borough, which has a higher than average prevalence of hepatitis C among injecting drug users compared to London as a whole.
    UK, England, Greater London Feb 2015 Case study Video
  • Hepatitis C in London
    This Public Health England report focuses on the epidemiology of hepatitis C in London, and provides recommendations for stakeholders on measures to prevent further infections and reduce morbidity and mortality of those already infected with the virus.
    UK, England, Greater London Feb 2015 Reports & Research, Strategy & Planning PDF

Pages